Oculis Holding (NASDAQ:OCS) announced it has randomized the first patient in its PREDICT-1 clinical trial, marking the launch of the first genotype-based registrational study aimed at treating dry eye disease.
Intesa Sanpaolo CEO Carlo Messina discusses the lender's offer to buy Italian rival Banca Monte dei Paschi for 30.6 billion ($35.3 billion). "The only real offer now in the market is the Intesa Sanpaolo offer," Messina tells Bloomberg's Francine Lacqua, calling Banco BPM's proposal of a merger of equals merely a "love letter."
Zepp Health (NYSE:ZEPP) reported a 33.8% increase in first-quarter revenue for fiscal year 2026, driven by robust momentum from its updated premium hardware portfolio during what is traditionally a softer seasonal cycle for consumer electronics.
Ten years after Brexit, analysis published by Bloomberg on Tuesday shows that the UK's vote to leave the European Union may have already cost the British economy between 2% and 4% of gross domestic product. Dan Hanson of Bloomberg Economics explains.
Baidu (NASDAQ:BIDU) confirmed that the U.S. Department of Defense has included the company on its updated list of "Chinese military companies," a classification the internet search and artificial intelligence giant quickly pushed back against as entirely unjustified.
NIO (NYSE:NIO) confirmed that the U.S. Department of Defense has added the company to its updated list of "Chinese military companies," prompting a swift pushback from the electric vehicle manufacturer as it prepares to contest the designation.
Anna Edwards, Tom Mackenzie and Adam Linton break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."
PureTech Health reported that its founded entity, Seaport Therapeutics (NASDAQ:SPTX), achieved positive clinical results from the multiple-ascending dose portion of its Phase 1 proof-of-concept trial evaluating its lead anti-anxiety candidate, GlyphAgo.
EHang Holdings (NASDAQ:EH) reported a widening net loss for the first quarter of fiscal 2026 as near-term commercial deliveries of its flagship autonomous aircraft slowed.
ASE Technology Holding (NYSE:ASX) reported a sharp acceleration in its monthly sales, driven by strong global momentum for its outsourced semiconductor backend services.
GSK agreed to buy Nuvalent in a deal valued at $10.6 billion, adding a biotech firm that's developing treatments for lung cancer as the British pharmaceutical company seeks to rebuild its oncology franchise. Sam Fazeli of Bloomberg Intelligence has more.
Apple (NASDAQ:AAPL) has launched a new suite of parental safety features explicitly inspired by Australia's world-first social media age ban.
_1417610_640x360_2503002691644-640x360.webp&w=3840&q=75)
_1417604_640x360_2503005251636-640x360.webp&w=3840&q=75)
_1417563_640x360_2503007299812-640x360.webp&w=3840&q=75)
